To investigate the clinical safety and efficacy of a temporary self-expanding metallic stent (SEMS) for malignant colorectal obstruction. patients with malignant colorectal obstruction were treated with a temporary SEMS. The stent had a tubular configuration with a retrieval lasso attached inside the proximal end of the stent to facilitate its removal. The SEMS was removed one week after placement. Clinical examination, abdominal X-ray and a contrast study were prospectively performed and both initial and follow-up data before and at 1 d, 1 wk, and 1 mo, 3 mo, 6 mo and 12 mo after stent placement were obtained. Data collected on the technical and clinical success of the procedures, complications, need for reinsertion and survival were analyzed.
INTRODUCTION
Over the last decade, colorectal stenting has been repo rted to be an effective method of relieving colonic ob struction in palliative treatment [15] or as a preoperative bridge to facilitate onestage surgical resection of pri mary colonic tumors [610] . Overall technical and clinical success has been reported in 80%100% of treated pa tients [1115] . However, metallic stent placement has been plagued by tumor ingrowth (3%46%) following bare stent placement [1619] , perforation (4%) [12, 13, 15, 20] , and stent migration (30%50%) [10, 2124] following covered stent placement.
To overcome these problems, a temporary expand able colorectal stent was devised for use in patients with unresectable malignant colorectal obstruction. Our hy pothesis was that the duration of placement of the self expanding colorectal stent could be reduced to prevent perforation and stent migration. The purpose of this study was to evaluate the clinical safety and efficacy of a temporary selfexpandable colorectal stent for the treat ment of unresectable malignant colorectal obstruction, with a focus on preventing colonic perforation and stent migration.
MATERIALS AND METHODS

Study design
This pilot study was approved by the Institutional Re view Board, and informed consent was obtained from all the patients. From September 2007 to June 2012, con secutive patients with malignant colorectal obstruction were treated with a temporary selfexpanding metallic stent (MicroTech, Nanjing, China) in our department.
Diagnoses were established by reviewing patient his tories, computed tomography (CT) imaging, colon stud ies and pathologic results. Patients were eligible for this procedure if the following criteria were met: (1) docu mented malignancy; (2) colorectal obstruction as defined by symptoms resulting in difficulty in defecation; (3) expandable metallic stent placement; and (4) life expec tancy of more than 6 mo. Exclusion criteria were: (1) nonsymptomatic patients with malignant colorectal ob struction; (2) clinical evidence of perforation or perito nitis combined with multiple smallbowel obstructions;
(3) extension of rectal cancer to the anal sphincter; and (4) right-sided acute obstruction (due to difficult access).
Stent
The colon stent (MicroTech) is woven from a single thread of highly elastic nitinol wire 0.16 mm in diameter. The stent had a tubular configuration with an elliptic structure at the proximal and distal ends. The body sec tion was 2530 mm in diameter when fully expanded and 70100 mm in length. The elliptic structure at the proxi mal and distal ends was 5 mm wider in diameter than the body section and 10 mm in length. To facilitate removal of the stent, a retrieval lasso was attached inside the proximal end of the stent to allow removal after place ment. For implantation under fluoroscopic guidance, the stent was delivered in a compressed form inside an introducer sheath with a diameter of 16 F.
Stent placement technique
The procedure was performed by one senior interven tional radiologist (Yang RM), who had 18 years of ex perience in interventional radiology, under fluoroscopic guidance. Neither analgesia nor sedation was adminis tered during the procedure.
Patients were initially placed in the left lateral de cubitus position. Rotating the patient into the supine position allowed for a better anatomic view under fluo roscopy. The site of obstruction was established both endoscopically by direct vision and with water soluble contrast (Ultravist 300, Schering, Guangzhou, China) ad ministered via a catheter passed through the endoscope and into the stricture. The procedure we used has been described elsewhere [1, 6, 7, 10, 25] . After the anal sphincter was lubricated, the distal ends of the tumors were identified by endoscopy. Then, a 0.035inch guide wire (Radiofocus M; Terumo, Tokyo, Japan) with a 5Fr catheter (Torcon NB; Cook, Bloomington, United States) was advanced and passed through the area of the stricture. The stric ture location, length and morphology of the colon were identified by the injection of 30% diluted nonionic con trast medium (Ultravist) via the catheter. To avoid perfo ration, balloon dilation was not generally performed. Af ter exchanging the guide wire for a 0.035inch superstiff guide wire (Boston Scientific/MediTech, Watertown, United States), a 16Fr delivery system (MicroTech) was passed over the stiff guide wire until the proximal and distal edges of the prosthesis bridged the stricture under fluoroscopic control, and the stent was then deployed by pulling back the introducer sheath. Finally, contrast medium (Ultravist) was injected through the catheter to assess correct placement and expansion of the stent.
Upon completion of the procedure, patients were transferred to the ward for observation. Once obstruc tive symptoms had remitted about one week after stent placement, the stent was grasped by the retrieval lasso and gently pulled out. A contrast study was performed to evaluate the patency to rule out possible concomitant lesions in the proximal and distal colon.
Postoperative outcome evaluation
Before SEMS placement, a routine workup, including CT of the abdomen and chest, as well as calculation of Karnofsky performance status, was conducted. An abdominal radiograph was taken during hospitalization 1-3 d after placement to confirm the correct deployment and expansion. After successful removal of the stent, patients were monitored in the outpatient clinic until either death, surgery was performed, patient was lost to followup or a complication developed. Clinical exami nation, abdominal Xray and a contrast study were per formed by two of our authors, who gathered both initial and followup data before and at 1 d, 1 wk, and 1 mo, 3 mo, 6 mo and 12 mo after stent placement. In cases where clinical exams could not be performed, data were obtained by means of telephone calls to the patient or the closest relative and by reviewing medical records. CT examination or an endoscopic procedure was performed if there was persistence or reappearance of symptoms such as abdominal pain, constipation, or rectal bleeding. Technical and clinical success of the procedure, occur rence and timing of complications, and the need for sur gical intervention were analyzed.
Patients were considered to have incurable cancer when curative resection of metastatic disease was im possible due to extensive liver metastases or extrahe patic disease. Technical success was defined as success ful placement of the SEMS, with correct deployment, positioning at the level of the stenosis, and removal of the stent determined with radiologic procedures. Clinical success was defined as complete colonic decompression and relief of obstructive symptoms as judged by clini cal symptoms and radiographic observations, without intervention or devicerelated complications within 72 h after SEMS removal. Death was considered to be re lated to SEMS complications if the patient died within 7 d of insertion or removal. Major complications were events leading to surgery or reintervention or requiring admission to the intensive care unit. Perforation, stent obstruction, and migration were considered to be major complications. Mild complications were events leading to rehospitalization or prolonged hospital stay without fulfilling the major complications criteria.
Statistical analysis
Descriptive data are expressed as the mean ± SD. Cat egorical data are reported as numbers and percentages. Time to considered end points (occurrence of complica tions, surgical intervention, or death) was determined. KaplanMeier analysis of relief of obstructive symp toms was performed to calculate the cumulative rate of clinical success, such as sustained relief of obstruction and lack of complications. All statistical analyses were performed using the SPSS package, version 13.0 (SPSS, Chicago, Illinois, United States).
RESULTS
Patients
A total of 38 patients were included in this study initially. Five of these were excluded due to patients being lost to followup, thus, a total of 33 eligible patients were included (19 men, 14 women; mean age 61.55 ± 14.59 years, range 3085 years). Stenoses were located in: the transverse colon (n = 3); left colon (n = 7); sigmoid co lon (n = 12); rectum (n = 11). The mean distance of the lesion from the anus was 19.23 cm (range 571 cm), and the mean lesion length was 5.97 ± 2.07 cm (range 412 cm). The obstructions were complete (with no passage of contrast medium during contrast studies before or during stent placement) in 8 patients and incomplete in the remaining 25 patients.
Technical and initial clinical results
Stent placement in the target colon stricture was techni cally successful in all patients without procedurerelated complications. Initially, all patients required the place ment of one stent to cover the length of the obstruction. Complete expansion of the placed stent occurred within 2 d of stent placement. No patient underwent balloon dilation, either before or after stent placement. The mean procedure time was 42 min (range 30120 min). Removal of the stents was successful in all patients.
In patients with technically successful removal of the stent, clinical success was achieved in 31 of the 33 patients within 72 h of removal, with a success rate of 93.9%. Two patients who did not achieve clinical success after removal of the stents due to paralytic ileus or ex tension of the tumor were retreated with the stent.
Complications
No perforations occurred following placement or re moval of the stents. Stent migration occurred in 2 pa tients (distal partial migration in two patients), and none of these patients required a second stent placement due to improvement of the obstruction at the time of stent removal. Two patients who had a stent placed in the rec tum complained of moderate rectal pain within 2 d of stent placement without requiring analgesics.
Follow-up results
Eleven of the 33 patients died 73.81 ± 23.66 d (range 42121 d) after removal of the stent without colonic re obstruction due to diffuse metastatic cancer, cachexia, or myocardial infarction. Clinical success was achieved in 8 patients without symptoms of obstruction. Stent rein sertion was performed in the remaining 12 patients with reobstruction after a mean followup period of 84.33 ± 51.80 d (range 27201 d). The mean and median periods of relief of obstructive symptoms were 97.25 ± 9.56 d (95%CI: 79, 116) and 105 ± 17.43 d (95%CI: 70, 139), respectively, using KaplanMeier analysis.
DISCUSSION
The present study was designed to test the hypothesis that a temporary selfexpanding metallic colorectal stent could reduce the risk of colonic perforation and stent migration. In this uncontrolled prospective study of 33 patients with unresectable malignant colorectal ob struction, temporary selfexpanding metallic colorectal stent placement was technically successful in all patients with a clinical success rate of 93.9%. There was no pro cedurerelated mortality or perforations in this study, and all complications were managed without surgical intervention. These results suggest that a temporary self expanding metallic colorectal stent can be considered a viable and effective treatment for patients with unresect able malignant colorectal obstruction. To date, this is the first report to describe the treatment of unresectable malignant colorectal obstruction with a temporary self expanding metallic colorectal stent.
Colonic or rectal stent placement is associated with some complications, including stent migration, perfora tions, rectal bleeding, fecal impaction, abdominal pain, and tenesmus, of which stent migration and perforation are the most serious complications. In systematic re views, migration was reported to occur in approximately 10%12% of patients [15, 20] , and is usually detected on followup radiographs within 1 wk of insertion. A com paratively small diameter and limited flexibility may have contributed to the more frequent occurrence of stent migration in earlier studies [26] . Although, Repici et al [1] and Song et al [6] have reported a lower migration rate (2% and 3%, respectively) with the use of the newly designed colorectal stents WallFlex stent and dual stent (with a large diameter and flared ends) in the treatment of ma lignant colorectal obstruction, however, these stents may result in another serious complication perforation [6] . Song et al [6] reported the lowest migration rate (0%) in the bridgetosurgery group, but they also yielded the highest complication rate colon perforation (22%) in 11 of the 50 patients in the same group after successful placement of the dual stent.
Perforation is found in 3.7%4.0% of patients with a colorectal SEMS [15, 20] , which is lower than stent migra tion, but it is the most serious complication which may threaten the life of patients. Balloon dilatation of a stric ture to obtain access can result in excessive manipulation of the wire through the colonic wall and anatomical sites with a comparatively high perforation risk. It is probable that stent design and longterm placement may play an important role in colonic perforation. Large diameter stents with flared ends and the stent eroding through the colonic wall during colonic peristalsis may directly result in perforation.
The ideal colorectal stent should have adequate radial expansile force and smooth edges. Enough radial ex pansile force is spontaneously and evenly generated, and the final diameter is reached over the course of 2-5 d, so that dilation of the stricture is gentle, as well as effec tive [27] . Thus, predilation is not generally necessary, and the potential for migration is reduced. A colorectal stent with smooth edges, obviating sharp hooks in the stent design, can maximally reduce the risk of perforation. The stent made by MicroTech has a relatively large pro file and an elliptic structure to prevent stent migration, and the elliptic structure has a shrunken edge at both sides to minimize the risk of perforation and satisfies the requirements for prevention of perforation.
The significant improvement in perforation rate and stent migration during the followup period in the pres ent study was predominantly attributable to the stent design and its temporary use, and demonstrated that the stent can be safely used in malignant colorectal obstruc tion. Our 93.9% clinical success rate in the relief of colonic obstruction following stent removal was in line with that of other researchers who reported 80%100% relief of colonic obstruction in patients with malignant colorectal obstruction treated with SEMSs [5, 9, 14, 15, 20] , and demonstrated the efficacy of the temporary stent for pa tients with malignant colorectal obstruction.
Our results have important clinical implications. The use of a temporary selfexpanding metallic colorectal stent rather than a longterm selfexpanding metallic colorectal stent in patients with unresectable malignant colorectal obstruction will substantially decrease the risk of perforation and stent migration. The findings from this study may encourage more studies on temporary selfexpanding metallic colorectal stents in the pallia tive treatment of patients with unresectable malignant colorectal obstruction.
Our study has some limitations. The number of pa tients treated was relatively small with a short lifespan, and death due to rapid progression of the disease may have masked both the benefits and risks of the pro cedure. Secondly, we did not include a control group, therefore, future randomized trials are needed to com pare the temporary selfexpanding metallic colorectal stent with the longterm selfexpanding metallic colorec tal stent in terms of efficacy, risk of complications, and recurrent obstruction, with particular attention to stent migration, tumoral and nontumoral tissue overgrowth and perforation.
In conclusion, our preliminary study demonstrated that the temporary SEMS was a safe and effective ap proach for colon decompression in patients with colorec tal malignant obstruction, with a low rate of complica tions and good mediumterm outcomes. Reinsertion of the stent can be performed in patients with reobstruc tion. Although the initial results are promising, longer followup and expanded clinical trials are needed.
COMMENTS
Background
Colorectal stenting has been reported to be an effective method of relieving colonic obstruction, however, metallic stent placement has been plagued by tumor ingrowth, perforation and migration.
Research frontiers
A temporary self-expanding metallic stent (SEMS) has been widely used for the treatment of patients with malignant esophageal stenosis, however, the use of this type of stent in patients with malignant colorectal obstruction has rarely been reported. Authors investigated the clinical safety and efficacy of a temporary self-expandable colorectal stent for malignant colorectal obstruction.
Innovations and breakthroughs
A temporary SEMS was specially devised for the management of patients with malignant colorectal obstruction associated with colonic cancer. All procedures were performed under fluoroscopic control. This is the first study to report the use of a temporary SEMS for malignant colorectal obstruction.
Applications
By determining the efficacy and safety of a temporary SEMS, this may provide a new therapeutic intervention for the treatment of patients with malignant colorectal obstruction.
Terminology
Malignant colorectal obstruction is a common presentation of colorectal cancer, accounting for about 15%-20% of initial presentations in patients with colorectal malignancy.
Peer review
The authors present a prospective study of temporary SEMS for malignant colorectal obstruction, with the aim of investigating the clinical safety and efficacy of the approach. The results reveal that the clinical success was achieved in 31 (93.9%) of 33 patients with resolution of bowel obstruction within 3 d after stent removal, as well as lower complication rates. In addition, the mean and median periods of relief of obstructive symptom were 97.25 ± 9.56 d and 105 ± 17.43 d, respectively. The results are interesting. A temporary SEMS may be a good attempt to seek the new clinical therapy for unresectable colorectal cancer patients and has a potential clinical significance.
